ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1837

Depression and Suicide Attempt in Systemic Lupus Erythematosus with and Without Fibromyalgia

Irakli Tskhakaia1, Pushti Khandwala1 and Irene Tan2, 1Albert Einstein Medical Center Philadelphia, Philadelphia, PA, 2Einstein Medical Center Philadelphia, Bala Cynwyd, PA

Meeting: ACR Convergence 2023

Keywords: depression, fibromyalgia, Social support, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1827–1839) Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Suicide and depression represent a high burden of morbidity and mortality worldwide. It is well known that fibromyalgia (FM) is associated with mood and behavioral disorders. FM is extremely common in patients with systemic lupus erythematosus (SLE) even though FM does not correlate with SLE activity. We investigate the rate of concomitant depressive disorder and suicide attempts in patients with SLE.

Methods: TrinetX, a global federated research network that provides a dataset of electronic medical records from different healthcare organizations (HCOs) was utilized. Initial query was made on June 6, 2023 from 1/1/2010 to 6/6/2023 to identify patients aged >18 with a diagnosis of “Systemic Lupus Erythematosus” (International Classification of Diseases, 10th version (ICD-10) Code M32). Two cohorts were made, on the basis of the presence of a diagnosis of “Fibromyalgia” (ICD-10 Code M79.7). Propensity score matching was carried out to match age, race , and gender. Compare outcome analytic function was utilized to map the correlation with “Suicide attempt” (ICD 10 Code T14.91) and “Major Depressive Disorder (MDD)” (ICD 10 Code F33), and prevalence Odds ratios (OR) were calculate

Results: We identified cohort 1 as patients with concomitant diagnoses of SLE and FM with a total of 55,350 patients. Cohort 2 as SLE patients without FM included 219,914 patients. Using propensity score matching, patients with SLE but without FM were matched 1:1 to 53,221 patients with both SLE and FM. Data demonstrated mean age of 55.6 years (SD 14.6). Percentage of females in cohort 1 was 93.978% and 93.969% in cohort 2 with the white race being the most prevalent followed by unknown ethnicity, African-American and Asian. A total of 5,864 patients with SLE and FM also had a diagnosis of “Major Depressive Disorder” (ICD 10 Code F33), compared to 2,255 patients without FM, with a 6.781% risk difference (95% CI – 6.465%-7.097%, p < 0.0001), and Odds ratio of 2.799 (2.662-2.943, p< 0.0001). In addition, 625 patients with SLE and FM also had a diagnosis of “Suicide Attempt” (ICD 10 Code T14.91), compared to 238 patients without FM, with 0.727% risk difference (95% CI – (0.619%,0.835%), p < 0.0001), and Odds ratio of 2.645 (2.277-3.073, p< 0.0001), see table 1. Similar results were identified before propensity score matching, with OR of concomitant MDD in patients with SLE and FM compared to the cohort without FM being 3.146 (3.037-3.258, p< 0.0001) and OR of Suicide Attempt being 2.653 (2.396-2.938, p < 0.0001.

Conclusion: In this real-world, real-time study, patients with SLE and concomitant fibromyalgia have increased risk of major depressive disorder and suicide attempt when compared with SLE patients without fibromyalgia.

Supporting image 1


Disclosures: I. Tskhakaia: None; P. Khandwala: None; I. Tan: None.

To cite this abstract in AMA style:

Tskhakaia I, Khandwala P, Tan I. Depression and Suicide Attempt in Systemic Lupus Erythematosus with and Without Fibromyalgia [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/depression-and-suicide-attempt-in-systemic-lupus-erythematosus-with-and-without-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-and-suicide-attempt-in-systemic-lupus-erythematosus-with-and-without-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology